UCLA Researchers Find Molecular "Tweezer" Drug Shows Promise in Stopping Parkinson's Progression - 03/04/2013

Here is just one of the promising research projects that Team Parkinson is helping to fund with your help!

Parkinson’s disease (PD), suffered by more than 500,000 people in the United States alone, is a disorder of the central nervous system that affects movement and worsens over time. As the Baby Boomers age, it is estimated that the number of people with the disease will rise accordingly. Yet, despite several effective therapies to treat the symptoms of Parkinson’s, nothing slows its progression. Enter UCLA’s Movement Disorders Program, under the direction of Jeff Bronstein, M.D., Ph.D.

“The goal of the UCLA Movement Disorders Program is to improve the quality of life for people with Parkinson’s disease and other movement disorders,” says Dr. Bronstein. “Our secondary goal is to do everything we can with established treatments. We provide comprehensive and holistic care, taking the entire patient into account. Long-term, we hope to develop new potential therapies and ultimately stop
the progression of the disease, but first we need to develop these therapies in basic science labs, and then create a strong clinical trial center to test new treatments.” Click here to read the full report.